Three-year follow-up of the European multicenter tacrolimus (FK506) liver study

References

Page 1

	Year	Citations
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation The U.S. Multicenter FK Liver Study Group New England Journal of Medicine	1994	917
Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection The Lancet Transplant RejectionTransplantationHepatologyMedicineImmunosuppressive Therapy	1994	658
Liver, Kidney, and Thoracic Organ Transplantation Under FK 506 Satoru Todo, John J. Fung, Thomas E. Starzl, Annals of Surgery Solid Organ TransplantationImmunologyPathologyTranslational MedicineOrgan Procurement	1990	253
Two-year data from the European multicentre tacrolimus (F 06) liver study Roger Williams, P. Neuhaus, Henri Bismuth, Transplant International	1996	52
Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation P. Neuhaus, P McMaster, R. Y. Calne, Transplant International	1994	42
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study Bo‐Göran Ericzon, C. G. Groth, Henri Bismuth, Transplant International	1994	29
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients J Devlin, R. Williams, P. Neuhaus, Transplant International	1994	24
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation G. Otto, J. Bleyl, P. Neuhaus, Transplant International	1994	13
Patient and graft survival in the European Multicentre Liver Study - FK 506 vs cyclosporin A P McMaster Transplant International	1994	12
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation M. Winkler, Klinik für Abdominal, P. Neuhaus, Transplant International	1994	12

Page 1